Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers-Reference-Cited by-同舟云学术

Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers

Published:2018-01-03 Issue:8 Volume:59 Page:1949-1958
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Walz Juliane Sarah¹,Kowalewski Daniel Johannes²,Backert Linus²³,Nelde Annika¹²,Kohlbacher Oliver³⁴⁵,Weide Benjamin⁶,Kanz Lothar¹,Salih Helmut Rainer¹⁷,Rammensee Hans-Georg²⁸,Stevanović Stefan²⁸

Affiliation:

1. Department of Hematology and Oncology, University of Tübingen, Tübingen, Germany;

2. Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany;

3. Applied Bioinformatics, Center for Bioinformatics and Department of Computer Science, University of Tübingen, Tübingen, Germany;

4. Quantitative Biology Center, University of Tübingen, Tübingen, Germany;

5. Biomolecular Interactions, Max Planck Institute for Developmental Biology, Tübingen, Germany;

6. Department of Dermatology, University Hospital Tübingen, Tübingen, Germany;

7. Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Tübingen, Tübingen, Germany;

8. German Cancer Consortium (DKTK), DKFZ Partner Site Tübingen, Tübingen, Germany

Funder

German Cancer Consortium (DKTK)

Deutsche Forschungsgemeinschaft

Wilhelm Sander-Stiftung

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1403022

Reference52 articles.